Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products–a PEARRL review

M Guimarães, M Statelova, R Holm… - Journal of Pharmacy …, 2019 - academic.oup.com
Objectives In this review, the current biopharmaceutical approaches for evaluation of oral
formulation performance in paediatrics are discussed. Key findings The paediatric …

Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children

BP Gonçalves, H Pett, AB Tiono, D Murry… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Low-dose primaquine is recommended to prevent Plasmodium falciparum malaria
transmission in areas threatened by artemisinin resistance and areas aiming for malaria …

Physiologically based pharmacokinetic modeling and allometric scaling in pediatric drug development: Where do we draw the line?

TN Johnson, AB Ke - The Journal of Clinical Pharmacology, 2021 - Wiley Online Library
Developing medicines for children is now established in legislation in both the United States
and Europe; new drugs require pediatric study or investigation plans as part of their …

How does in vivo biliary elimination of drugs change with age? Evidence from in vitro and clinical data using a systems pharmacology approach

TN Johnson, M Jamei, K Rowland-Yeo - Drug Metabolism and Disposition, 2016 - ASPET
Information on the developmental changes in biliary excretion (BE) of drugs is sparse. The
aims of this study were to collate literature data on the pharmacokinetics of biliary excretion …

Moving from point‐based analysis to systems‐based modeling: integration of knowledge to address antimicrobial resistance against MDR bacteria

E Garcia, N Ly, JK Diep, GG Rao - Clinical Pharmacology & …, 2021 - Wiley Online Library
The emerging discipline of Quantitative Systems Pharmacology (QSP) enables the
integration of quantitative experimental data describing the interactions between the various …

The use of PBPK modeling across the pediatric age range using propofol as a case

R Michelet, J Van Bocxlaer, K Allegaert… - … of Pharmacokinetics and …, 2018 - Springer
The project SAFEPEDRUG aims to provide guidelines for drug research in children, based
on bottom-up and top-down approaches. Propofol, one of the studied model compounds …

Reduced Physiologically-Based Pharmacokinetic Model of Repaglinide: Impact of OATP1B1 and CYP2C8 Genotype and Source of In Vitro Data on the Prediction of …

M Gertz, N Tsamandouras, C Säll, JB Houston… - Pharmaceutical …, 2014 - Springer
Purpose To investigate the effect of OATP1B1 genotype as a covariate on repaglinide
pharmacokinetics and drug-drug interaction (DDIs) risk using a reduced physiologically …

Computational modeling of the cell-autonomous mammalian circadian oscillator

OA Podkolodnaya, NN Tverdokhleb… - BMC systems …, 2017 - Springer
This review summarizes various mathematical models of cell-autonomous mammalian
circadian clock. We present the basics necessary for understanding of the cell-autonomous …

Practical understanding of cancer model identifiability in clinical applications

T Phan, J Bennett, T Patten - Life, 2023 - mdpi.com
Mathematical models are a core component in the foundation of cancer theory and have
been developed as clinical tools in precision medicine. Modeling studies for clinical …

The safety evaluation of food flavouring substances: the role of metabolic studies

RL Smith, SM Cohen, S Fukushima… - Toxicology …, 2018 - academic.oup.com
The safety assessment of a flavour substance examines several factors, including metabolic
and physiological disposition data. The present article provides an overview of the …